The Epilepsy Support Group of Newcastle will be at Waratah Village Shopping Centre on March 26 raises funds and awareness and offering information on epilepsy in the community.
Category: Epilepsy
Scientists creating method to break down drugs in wastewater
Scientists from the Wackett Lab are using a predictive method to determine the correct enzymes that break down pharmaceuticals in water, The Minnesota Daily reported . The method calculates the likelihood that a drug can eventually break down.
Aequus Licenses Rights to Cannabinoid Transdermal Patch to Treat Neurological Disorders
Aequus has been focused on expanding treatment options for neurological disorders through its current pipeline of development stage and in-licensed products. Aequus recognizes there has been an increased acceptance around the use of cannabinoids for epilepsy and MS in particular, however, uptake by the medical community has been limited by a need for a product that provides precise, controlled dose delivery.
Supernus to Present at Cowen Health Care Conference in March
Supernus Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, today announced that the Company’s management will present an overview and update of the company and host investor meetings at the Cowen & Company 37th Annual Health Care Conference. A live webcast of the presentation can be accssed by visiting ‘Events & Presentations’ in the Investors Section on the Company’s website at www.supernus.com .
FDA Grants de novo Clearance for the Brain Sentinel Monitoring…
Brain Sentinel’s SPEAC System provides the epilepsy community with a new tool for seizure monitoring when EEG is not feasible. The SPEAC System is the first non-EEG, physiological, signal-based seizure monitoring system cleared by the FDA.
Epilepsy group seeks to enlist help to fight illness
The Epilepsy Foundation of Guyana on Monday hosted a discussion with several stakeholders to enlist their help to raise awareness about the illness and available treatment. The discussion coincided with the observance of International Epilepsy Day, under the theme ‘Putting Epilepsy in the Picture.’
Epilepsy drug discovered in fish model shows promise in small pediatric clinical trial
… supported by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health. “This is the first time that scientists have taken a potential therapy discovered in a fish model directly into people in a …
Supernus Announces Issuance of Eighth U.S. Patent Protecting Trokendi XR
Supernus Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, today announced the issuance on January 31, 2017 of an eighth patent by the United States Patent and Trademark Office covering Trokendi XR, its novel once-daily extended-release topiramate product. The patent provides protection for the product with expiration that is no earlier than 2027.
Legislature: Cannabis extract could treat epilepsy
Marijuana starts more debates than just about any drug in America, and tetrahydrocannabinol is usually the component of the plant that gets the most attention. Cannabidiol, or CBD, is a component of cannabis that creates none of the psycho-activity associated with THC.